Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Clinical data on inhaled Technosphere insulin disclosed at ADA

July 20, 2010

Merck & Co. describes novel GPR109B receptor agonists

July 20, 2010

Encouraging data disclosed on antidiabetes candidate TAK-875

July 20, 2010

Clinical and preclinical data suggest potential of teneligliptin in diabetes

July 20, 2010

Novo Nordisk completes recruitment in A1chieve trial of insulin regimens

July 19, 2010

FDA extends PDUFA date for Walter Chilcott's Actonel product

July 19, 2010

Canagliflozin improves glucose control in persons with type 2 diabetes

July 19, 2010

Schering discloses novel nicotinic acid receptor agonists

July 19, 2010

FDA advisory committee votes against approval of Qnexa for obesity

July 16, 2010

FDA committees vote to keep rosiglitazone on the market; Takeda defends pioglitazone

July 16, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst
BioWorld
Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...